https://blog.coinbase.com/gm-coinbase-nft-is-now-in-beta-25e6c052aa43
Morgan Stanley Maintains Equal-Weight on ADC Therapeutics, Lowers Price Target to $5
Morgan Stanley analyst Matthew Harrison maintains ADC Therapeutics (NYSE:ADCT) with a Equal-Weight and lowers the price target from $7 to $5.